摘要
近年来,通过对乙型肝炎病毒(HBV)转基因小鼠的研究发现:细胞毒性T淋巴细胞释放细胞因子介导的非细胞毒性机制可能在抗HBV感染中发挥更重要的作用。本文对非细胞 毒性作用的诱导方式、作用机制,以及与乙型肝炎发病机制的关系等方面进行综述。
参考文献18
-
1Guidotti LG et al. Proc Natl Acad Sci USA, 1994; 91:3764-3768
-
2FrancoAetal. JImmunol, 1997; 159 (4): 2001-2008
-
3Cavanaugh VJ et al. J Virol, 1999; 72: 2530-2637
-
4Guidotti LG et al. Proc Natl Acad Sci USA, 1996; 93(10): 4589-4594
-
5Pasquetto V et al. J Exp Med, 2000; 192:529-536
-
6Mcclary H et al. J Virol, 2000, 74:2255-2264
-
7Guidotti LG et al. Sciene, 1999; 284:825-829
-
8Tsui LV et al. Proc Natl Acad Sci USA, 1995; 92:12398-12402
-
9Huang ZM et al. J Virol, 1994, 68:3193-3199
-
10Heise T et al. J Virol. 1999; 73:474-481
同被引文献9
-
1Tan A, Yeh SH, Liu CJ, et al. Viral hepatocarcinogencsis: from infection to cancer[J]. Liver Int, 2008, 28(2): 175-88.
-
2Dumortier J, Schonig K, Oberwinkler H, et al. Liver-specific expression of interferon gamma following adonoviral gone transfer controls hepatitis B virus replication in mice[J]. Gone Ther, 2005, 12(8): 668-77.
-
3Shin EC, Protzer U, Untergasser A, et al. Liver-directed gamma interferon gene delivery in chronic hepatitis C[J]. J Virol, 2005, 79 (21): 13412-20.
-
4Guidotti LG, Ando K, Hobbs MV, et al. Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytie mechanism in transgenic mice [J]. Proc Natl Acad Sci USA, 1994, 91(9): 3764-68.
-
5Guidotti LG, Rechford R, Chung J. Viral clearance without destruction of infected cells during acute HBV infection [J]. Science, 1999, 284(5415): 825-9.
-
6Schultz U, Chisari FV. Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes [J]. J Virol, 1999, 73(4): 3162-8.
-
7Parvez MK, Sehgai D, Sarin SK, et al. Inhibition of hepatitis B virus DNA replicative intermediate forms by recombinant interferongamma[J].World J Gastroenterol, 2006, 12(19): 3006-14.
-
8McClary H, Koch R, Chisari FV, et al. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines [J]. J Virol, 2000, 74(5): 2255-64.
-
9成军,李莉.清除乙型肝炎病毒的非细胞裂解机制[J].世界华人消化杂志,2002,10(1):73-76. 被引量:49
-
1刘红娥,周金凤.RNA干扰技术及其抗乙型肝炎病毒的相关研究[J].中国现代药物应用,2009,3(8):198-200. 被引量:2
-
2张晓芳.急性乙型肝炎60例临床分析[J].南通大学学报(医学版),2008,28(6):525-526. 被引量:1
-
3李志群,朱思和,李志恒,成军,马英骥.非细胞毒性清除乙型肝炎病毒机制的研究[J].国际流行病学传染病学杂志,2006,33(2):96-99.
-
4陈治平.干扰素和拉米夫定联合抗乙型肝炎病毒效应[J].实用肝脏病杂志,2003,6(2):99-100. 被引量:2
-
5欧阳雁玲,李泽琳,曾毅.RNA干扰在抗HBV感染中作用的研究进展[J].中华实验和临床病毒学杂志,2005,19(3):297-299. 被引量:1
-
6费琰.拉米夫定药物不良反应分析[J].中华当代医学,2007,5(6):64-65. 被引量:1
-
7商庆华,于建国,肖德明,徐传镇,杜庆岭,康松华.血清HBV-DNA定量水平与拉米夫定抗HBV感染中YMDD变异的相关性研究[J].临床军医杂志,2004,32(6):1-4.
-
8王亚雄,曾滢,张宜俊.治疗性乙型肝炎疫苗研究进展[J].传染病信息,2008,21(3):139-142.
-
9王媛媛,韩涛.慢性乙型肝炎患者的细胞免疫[J].武警医学院学报,2008,17(4):341-343. 被引量:2
-
10王福生.抗HBV感染治疗中患者体内病毒学和耐药性等因素的动态变化及其临床意义[J].世界华人消化杂志,2003,11(2):130-133.